LLYEli Lilly
Regular session
$1214.81
+3.32%open $1175.72

A 3.32% intraday gain to $1,214.81 adds roughly $36 billion in market value, the kind of single-session swing a $1.1 trillion company rarely posts. Keep an eye on whether it holds into the close.

LLYEli Lilly
Regular session
$1213.48
+3.21%open $1175.72

A 3.2% intraday move to $1,213.48 adds roughly $35 billion of market value to a trillion-dollar drugmaker in a single session. Moves that size are rare for a name this big, so keep an eye on whether it holds into the close.

LLYEli Lilly
Regular session
$1135.59
-3.68%open $1179.02

A 3.7% slide to $1,135.59 shaves tens of billions off a trillion-dollar market cap in a single session, a rare swing for a megacap this size. Whether it holds above the open at $1,179.02 by the close is the thing to keep an eye on.

Cramer is calling a mispricing in the obesity drug race, arguing Lilly's latest wins over Novo Nordisk have not been paid for by the market yet.

LLY tons of powerful news versus Novo on weight loss drugs. Being ignored
  • Replies11
  • Reposts2
  • Likes41